A novel autoantibody targeting calreticulin is associated with cancer in patients with idiopathic inflammatory myopathies

OBJECTIVES: To investigate the prevalence and clinical significance of anti‐calreticulin autoantibodies (anti‐CRT Ab) in a large cohort of idiopathic inflammatory myopathy (IIM) patients. METHODS: Sera from 469 patients with IIM, 196 patients with other connective tissue diseases, 28 patients with s...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, He, Yang, Heng, Cheng, Qiu‐Xiang, Ge, Yong‐Peng, Peng, Qing‐Lin, Zhang, Ya‐Mei, Cheng, Gen‐Hong, Wang, Guo‐Chun, Lu, Xin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7558046/
https://www.ncbi.nlm.nih.gov/pubmed/33082955
http://dx.doi.org/10.1002/cti2.1195

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7558046/
https://www.ncbi.nlm.nih.gov/pubmed/33082955
http://dx.doi.org/10.1002/cti2.1195

Ejemplares similares